{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:46:38Z","timestamp":1792169198939,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,11,5]]},"DOI":"10.1038\/s41416-026-03563-2","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T09:47:10Z","timestamp":1785750430000},"page":"1402-1416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Super-enhancer landscape regulated by CDK12 drives retinoblastoma progression"],"prefix":"10.1038","volume":"135","author":[{"given":"Caiyao","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenfen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxia","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7306-7922","authenticated-orcid":false,"given":"Shenglan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"3563_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.101030","volume":"89","author":"P Chai","year":"2022","unstructured":"Chai P, Jia R, Li Y, Zhou C, Gu X, Yang L, et al. Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma. Prog Retin Eye Res. 2022;89:101030.","journal-title":"Prog Retin Eye Res"},{"key":"3563_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ophtha.2021.09.002","volume":"129","author":"C Zhou","year":"2022","unstructured":"Zhou C, Wen X, Ding Y, Ding J, Jin M, Liu Z, et al. Eye-preserving therapies for advanced retinoblastoma: a multicenter cohort of 1678 patients in China. Ophthalmology. 2022;129:209\u201319.","journal-title":"Ophthalmology"},{"key":"3563_CR3","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.neuron.2017.04.022","volume":"94","author":"I Aldiri","year":"2017","unstructured":"Aldiri I, Xu B, Wang L, Chen X, Hiler D, Griffiths L, et al. The dynamic epigenetic landscape of the retina during development, reprogramming, and tumorigenesis. Neuron. 2017;94:550\u201368.e510.","journal-title":"Neuron"},{"key":"3563_CR4","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1093\/neuonc\/noae109","volume":"26","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhuo R, Sun L, Tao Y, Li G, Zhu F, et al. Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation. Neuro Oncol. 2024;26:1878\u201394.","journal-title":"Neuro Oncol"},{"key":"3563_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13046-022-02428-9","volume":"41","author":"F Fang","year":"2022","unstructured":"Fang F, Lu J, Sang X, Tao YF, Wang JW, Zhang ZM, et al. Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia. J Exp Clin Cancer Res. 2022;41:225.","journal-title":"J Exp Clin Cancer Res"},{"key":"3563_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24137-1","volume":"12","author":"J Dong","year":"2021","unstructured":"Dong J, Li J, Li Y, Ma Z, Yu Y, Wang CY. Transcriptional super-enhancers control cancer stemness and metastasis genes in squamous cell carcinoma. Nat Commun. 2021;12:3974.","journal-title":"Nat Commun"},{"key":"3563_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1087","volume":"12","author":"W Dai","year":"2022","unstructured":"Dai W, Wu J, Peng X, Hou W, Huang H, Cheng Q, et al. CDK12 orchestrates super-enhancer-associated CCDC137 transcription to direct hepatic metastasis in colorectal cancer. Clin Transl Med. 2022;12:e1087.","journal-title":"Clin Transl Med"},{"key":"3563_CR8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cell.2015.08.063","volume":"163","author":"Y Wang","year":"2015","unstructured":"Wang Y, Zhang T, Kwiatkowski N, Abraham BJ, Lee TI, Xie S, et al. CDK7-dependent transcriptional addiction in triple-negative breast cancer. Cell. 2015;163:174\u201386.","journal-title":"Cell"},{"key":"3563_CR9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI177599","volume":"135","author":"SQ Liu","year":"2025","unstructured":"Liu SQ, Cheng XX, He S, Xia T, Li YQ, Peng W, et al. Super-enhancer-driven EFNA1 fuels tumor progression in cervical cancer via the FOSL2-Src\/AKT\/STAT3 axis. J Clin Investig. 2025;135:e177599.","journal-title":"J Clin Investig"},{"key":"3563_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51229-5","volume":"15","author":"L Curti","year":"2024","unstructured":"Curti L, Rohban S, Bianchi N, Croci O, Andronache A, Barozzi S, et al. CDK12 controls transcription at damaged genes and prevents MYC-induced transcription-replication conflicts. Nat Commun. 2024;15:7100.","journal-title":"Nat Commun"},{"key":"3563_CR11","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/cdd.2015.157","volume":"23","author":"HC Juan","year":"2016","unstructured":"Juan HC, Lin Y, Chen HR, Fann MJ. Cdk12 is essential for embryonic development and the maintenance of genomic stability. Cell Death Differ. 2016;23:1038\u201348.","journal-title":"Cell Death Differ"},{"key":"3563_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2024.101173","volume":"15","author":"W Dai","year":"2025","unstructured":"Dai W, Xie D, Huang H, Li J, Guo C, Cao F, et al. New insights into the dule roles CDK12 in human cancers: Mechanisms and interventions for cancer therapy. J Pharm Anal. 2025;15:101173.","journal-title":"J Pharm Anal"},{"key":"3563_CR13","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1093\/nar\/gkv101","volume":"43","author":"KM Ekumi","year":"2015","unstructured":"Ekumi KM, Paculova H, Lenasi T, Pospichalova V, B\u00f6sken CA, Rybarikova J, et al. Ovarian carcinoma CDK12 mutations misregulate expression of DNA repair genes via deficient formation and function of the Cdk12\/CycK complex. Nucleic Acids Res. 2015;43:2575\u201389.","journal-title":"Nucleic Acids Res"},{"key":"3563_CR14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1158\/1078-0432.CCR-20-3877","volume":"27","author":"TL Lotan","year":"2021","unstructured":"Lotan TL, Antonarakis ES. CDK12 deficiency and the immune microenvironment in prostate cancer. Clin Cancer Res. 2021;27:380\u20132.","journal-title":"Clin Cancer Res"},{"key":"3563_CR15","first-page":"355","volume":"26","author":"YZ Yi","year":"1990","unstructured":"Yi YZ, Jie J. [Establishment and characterization of a human retinoblastoma cell line SO-Rb50]. Zhonghua Yan Ke Za Zhi. 1990;26:355\u20139.","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"3563_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nature14136","volume":"517","author":"S Konermann","year":"2015","unstructured":"Konermann S, Brigham MD, Trevino AE, Joung J, Abudayyeh OO, Barcena C, et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. 2015;517:583\u20138.","journal-title":"Nature"},{"key":"3563_CR17","doi-asserted-by":"publisher","first-page":"8261","DOI":"10.1007\/s00018-021-04013-3","volume":"78","author":"S Liu","year":"2021","unstructured":"Liu S, He L, Wu J, Wu X, Xie L, Dai W, et al. DHX9 contributes to the malignant phenotypes of colorectal cancer via activating NF-\u03baB signaling pathway. Cell Mol Life Sci. 2021;78:8261\u201381.","journal-title":"Cell Mol Life Sci"},{"key":"3563_CR18","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nprot.2012.016","volume":"7","author":"C Trapnell","year":"2012","unstructured":"Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc. 2012;7:562\u201378.","journal-title":"Nat Protoc"},{"key":"3563_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139.","journal-title":"Nat Methods"},{"key":"3563_CR20","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20199156","volume":"16","author":"V Dubois","year":"2020","unstructured":"Dubois V, Gheeraert C, Vankrunkelsven W, Dubois-Chevalier J, Dehondt H, Bobowski-Gerard M, et al. Endoplasmic reticulum stress actively suppresses hepatic molecular identity in damaged liver. Mol Syst Biol. 2020;16:e9156.","journal-title":"Mol Syst Biol"},{"key":"3563_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45839-z","volume":"9","author":"HM Amemiya","year":"2019","unstructured":"Amemiya HM, Kundaje A, Boyle AP. The ENCODE Blacklist: Identification of Problematic Regions of the Genome. Sci Rep. 2019;9:9354.","journal-title":"Sci Rep"},{"key":"3563_CR22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","volume":"153","author":"WA Whyte","year":"2013","unstructured":"Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153:307\u201319.","journal-title":"Cell"},{"key":"3563_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh3462","volume":"13","author":"J Zhou","year":"2021","unstructured":"Zhou J, Wang S, Nie D, Lai P, Li Y, Li Y, et al. Super-enhancer landscape reveals leukemia stem cell reliance on X-box binding protein 1 as a therapeutic vulnerability. Sci Transl Med. 2021;13:eabh3462.","journal-title":"Sci Transl Med"},{"key":"3563_CR24","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923\u201330.","journal-title":"Bioinformatics"},{"key":"3563_CR25","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.1093\/nar\/gkw257","volume":"44","author":"F Ram\u00edrez","year":"2016","unstructured":"Ram\u00edrez F, Ryan DP, Gr\u00fcning B, Bhardwaj V, Kilpert F, Richter AS, et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 2016;44:W160\u20135.","journal-title":"Nucleic Acids Res"},{"key":"3563_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24\u20136.","journal-title":"Nat Biotechnol"},{"key":"3563_CR27","doi-asserted-by":"publisher","first-page":"W520","DOI":"10.1093\/nar\/gkad408","volume":"51","author":"FC Qian","year":"2023","unstructured":"Qian FC, Zhou LW, Li YY, Yu ZM, Li LD, Wang YZ, et al. SEanalysis 2.0: a comprehensive super-enhancer regulatory network analysis tool for human and mouse. Nucleic Acids Res. 2023;51:W520\u20137.","journal-title":"Nucleic Acids Res"},{"key":"3563_CR28","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.1093\/nar\/gky366","volume":"46","author":"P Chai","year":"2018","unstructured":"Chai P, Jia R, Jia R, Pan H, Wang S, Ni H, et al. Dynamic chromosomal tuning of a novel GAU1 lncing driver at chr12p13.32 accelerates tumorigenesis. Nucleic Acids Res. 2018;46:6041\u201356.","journal-title":"Nucleic Acids Res"},{"key":"3563_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42253-4","volume":"13","author":"Q Zeng","year":"2023","unstructured":"Zeng Q, Wang S, Chen L, Wang J. Transcriptome analysis reveals molecularly distinct subtypes in retinoblastoma. Sci Rep. 2023;13:16475.","journal-title":"Sci Rep"},{"key":"3563_CR30","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100811","volume":"38","author":"SW Lukowski","year":"2019","unstructured":"Lukowski SW, Lo CY, Sharov AA, Nguyen Q, Fang L, Hung SS, et al. A single-cell transcriptome atlas of the adult human retina. Embo J. 2019;38:e100811.","journal-title":"Embo J"},{"key":"3563_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04904-8","volume":"13","author":"C Wu","year":"2022","unstructured":"Wu C, Yang J, Xiao W, Jiang Z, Chen S, Guo D, et al. Single-cell characterization of malignant phenotypes and microenvironment alteration in retinoblastoma. Cell Death Dis. 2022;13:438.","journal-title":"Cell Death Dis"},{"key":"3563_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat9321","volume":"11","author":"G Pascual-Pasto","year":"2019","unstructured":"Pascual-Pasto G, Bazan-Peregrino M, Olaciregui NG, Restrepo-Perdomo CA, Mato-Berciano A, Ottaviani D, et al. Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01. Sci Transl Med. 2019;11:eaat9321.","journal-title":"Sci Transl Med"},{"key":"3563_CR33","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1158\/1078-0432.CCR-24-0221","volume":"30","author":"G Pascual-Pasto","year":"2024","unstructured":"Pascual-Pasto G, McIntyre B, Giudice AM, Alikarami F, Morrissey A, Matlaga S, et al. Targeting GPC2 on Intraocular and CNS Metastatic Retinoblastomas with Local and Systemic Delivery of CAR T Cells. Clin Cancer Res. 2024;30:3578\u201391.","journal-title":"Clin Cancer Res"},{"key":"3563_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/ng.3167","volume":"47","author":"S Pott","year":"2015","unstructured":"Pott S, Lieb JD. What are super-enhancers? Nat Genet. 2015;47:8\u201312.","journal-title":"Nat Genet"},{"key":"3563_CR35","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s13287-023-03590-3","volume":"14","author":"D Pan","year":"2023","unstructured":"Pan D, Zhang X, Jin K, Jin ZB. CRX haploinsufficiency compromises photoreceptor precursor translocation and differentiation in human retinal organoids. Stem Cell Res Ther. 2023;14:346.","journal-title":"Stem Cell Res Ther"},{"key":"3563_CR36","doi-asserted-by":"publisher","DOI":"10.1242\/dev.187922","volume":"147","author":"CSY Chan","year":"2020","unstructured":"Chan CSY, Lonfat N, Zhao R, Davis AE, Li L, Wu MR, et al. Cell type- and stage-specific expression of Otx2 is regulated by multiple transcription factors and cis-regulatory modules in the retina. Development. 2020;147:dev187922.","journal-title":"Development"},{"key":"3563_CR37","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.7150\/thno.29380","volume":"8","author":"B Liu","year":"2018","unstructured":"Liu B, Du R, Zhou L, Xu J, Chen S, Chen J, et al. miR-200c\/141 Regulates Breast Cancer Stem Cell Heterogeneity via Targeting HIPK1\/\u03b2-Catenin Axis. Theranostics. 2018;8:5801\u201313.","journal-title":"Theranostics"},{"key":"3563_CR38","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1158\/0008-5472.CAN-22-3645","volume":"83","author":"D Rohila","year":"2023","unstructured":"Rohila D, Park IH, Pham TV, Weitz J, Hurtado de Mendoza T, Madheswaran S, et al. Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma. Cancer Res. 2023;83:2675\u201389.","journal-title":"Cancer Res"},{"key":"3563_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122788","volume":"350","author":"G Siragusa","year":"2024","unstructured":"Siragusa G, Tomasello L, Giordano C, Pizzolanti G. Survivin (BIRC5): Implications in cancer therapy. Life Sci. 2024;350:122788.","journal-title":"Life Sci"},{"key":"3563_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.144056","volume":"311","author":"J Qin","year":"2025","unstructured":"Qin J, Tang N, Huang D, Zhang Z, Lu G, Chen Y, et al. Integrated proteomic network analysis reveals PTPRC as a central hub protein orchestrating co-expression modules and metabolic dysregulation in renal carcinoma: PTPRC protein molecular action. Int J Biol Macromol. 2025;311:144056.","journal-title":"Int J Biol Macromol"},{"key":"3563_CR41","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1002\/hep.30544","volume":"69","author":"FH Tsang","year":"2019","unstructured":"Tsang FH, Law CT, Tang TC, Cheng CL, Chin DW, Tam WV, et al. Aberrant Super-Enhancer Landscape in Human Hepatocellular Carcinoma. Hepatology. 2019;69:2502\u201317.","journal-title":"Hepatology"},{"key":"3563_CR42","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/s42003-025-08430-z","volume":"8","author":"WD Yang","year":"2025","unstructured":"Yang WD, Zhang ZH, Zhao MY, Shao K, Ma YF, Shen Q, et al. P300-dependent acetylation of the FOXQ1 complex activates super-enhancers to promote colorectal cancer proliferation and metastasis. Commun Biol. 2025;8:1016.","journal-title":"Commun Biol"},{"key":"3563_CR43","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1136\/gutjnl-2016-311818","volume":"66","author":"YY Jiang","year":"2017","unstructured":"Jiang YY, Lin DC, Mayakonda A, Hazawa M, Ding LW, Chien WW, et al. Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma. Gut. 2017;66:1358\u201368.","journal-title":"Gut"},{"key":"3563_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04027-6","volume":"12","author":"H Lei","year":"2021","unstructured":"Lei H, Wang Z, Jiang D, Liu F, Liu M, Lei X, et al. CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer. Cell Death Dis. 2021;12:740.","journal-title":"Cell Death Dis"},{"key":"3563_CR45","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41589-021-00765-y","volume":"17","author":"B Jiang","year":"2021","unstructured":"Jiang B, Gao Y, Che J, Lu W, Kaltheuner IH, Dries R, et al. Discovery and resistance mechanism of a selective CDK12 degrader. Nat Chem Biol. 2021;17:675\u201383.","journal-title":"Nat Chem Biol"},{"key":"3563_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188887","volume":"1878","author":"P Verma","year":"2023","unstructured":"Verma P, Shukla N, Kumari S, Ansari MS, Gautam NK, Patel GK. Cancer stem cell in prostate cancer progression, metastasis and therapy resistance. Biochim Biophys Acta Rev Cancer. 2023;1878:188887.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3563_CR47","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.7150\/ijbs.94568","volume":"20","author":"J Liang","year":"2024","unstructured":"Liang J, Zhou X, Yuan L, Chen T, Wan Y, Jiang Y, et al. Olaparib combined with CDK12-IN-3 to promote genomic instability and cell death in ovarian cancer. Int J Biol Sci. 2024;20:4513\u201331.","journal-title":"Int J Biol Sci"},{"key":"3563_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60192-8","volume":"16","author":"R Almaghrabi","year":"2025","unstructured":"Almaghrabi R, Alyahyawi Y, Keane P, Mian SA, Habel K, Atkinson A, et al. A heterozygous CEBPA mutation disrupting the bZIP domain in a RUNX1 and SRSF2 mutational background causes MDS disease progression. Nat Commun. 2025;16:5489.","journal-title":"Nat Commun"},{"key":"3563_CR49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.canlet.2016.06.012","volume":"380","author":"G Pascual-Pasto","year":"2016","unstructured":"Pascual-Pasto G, Olaciregui NG, Vila-Ubach M, Paco S, Monterrubio C, Rodriguez E, et al. Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination. Cancer Lett. 2016;380:10\u201319.","journal-title":"Cancer Lett"},{"key":"3563_CR50","doi-asserted-by":"publisher","first-page":"8755","DOI":"10.7150\/thno.63446","volume":"11","author":"SY Park","year":"2021","unstructured":"Park SY, Kim JY, Jang GB, Choi JH, Kim JH, Lee CJ, et al. Aberrant activation of the CD45-Wnt signaling axis promotes stemness and therapy resistance in colorectal cancer cells. Theranostics. 2021;11:8755\u201370.","journal-title":"Theranostics"},{"key":"3563_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101964","volume":"45","author":"J An","year":"2024","unstructured":"An J, Chen P, Li X, Li X, Peng F. Identification of potential hub genes and biological mechanism in rheumatoid arthritis and non-small cell lung cancer via integrated bioinformatics analysis. Transl Oncol. 2024;45:101964.","journal-title":"Transl Oncol"},{"key":"3563_CR52","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.canlet.2006.03.007","volume":"244","author":"NK Sah","year":"2006","unstructured":"Sah NK, Khan Z, Khan GJ, Bisen PS. Structural, functional and therapeutic biology of survivin. Cancer Lett. 2006;244:164\u201371.","journal-title":"Cancer Lett"},{"key":"3563_CR53","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0140-6736(03)13910-4","volume":"362","author":"PJ Kim","year":"2003","unstructured":"Kim PJ, Plescia J, Clevers H, Fearon ER, Altieri DC. Survivin and molecular pathogenesis of colorectal cancer. Lancet. 2003;362:205\u20139.","journal-title":"Lancet"},{"key":"3563_CR54","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s13046-019-1362-1","volume":"38","author":"F Li","year":"2019","unstructured":"Li F, Aljahdali I, Ling X. Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study? J Exp Clin Cancer Res. 2019;38:368.","journal-title":"J Exp Clin Cancer Res"},{"key":"3563_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09371-0","volume":"22","author":"A F\u00e4ldt Beding","year":"2022","unstructured":"F\u00e4ldt Beding A, Larsson P, Helou K, Einbeigi Z, Parris TZ. Pan-cancer analysis identifies BIRC5 as a prognostic biomarker. BMC Cancer. 2022;22:322.","journal-title":"BMC Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03563-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03563-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03563-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:57:23Z","timestamp":1792166243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03563-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,11,5]]}},"alternative-id":["3563"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03563-2","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study adhered to the Declaration of Helsinki and received approval from the Institutional Ethics Committee of the First Affiliated Hospital of Gannan Medical University (Approval number: 2020142). All animal experimental protocols were conducted in compliance with relevant guidelines and reported following ARRIVE guidelines (\n                      \n                      ), with approval from the Animal Care and Use Committee at Gannan Medical University (Approval number: 2022181). All procedures were performed in accordance with applicable guidelines and regulations. Informed consent was obtained from all participants or their guardians.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}